A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 16.69%.However, over the last six months, we can
The market performance of Kintara Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $4.59 on 10/19/23, with the lowest value for the same timeframe being $0.08, recorded on 03/12/24. 52-week price history of KTRA Stock Analyzing
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -1.24%. However, over the past six months, we’ve seen a weaker performance of 86.53%. The
Kintara Therapeutics, Inc. (KTRA), a clinical-stage drug development company, closed Monday’s regular trading session at $0.50 after rocketing by 35.41% during the day. In the aftermarket, KTRA stock has further surged by 3.43% and as a result, is trading at $0.52 at the time of
All rights reserved © 2024, Powered By Smart TechOne
